October 15, 2026 Man claims he went blind after taking Ozempic, shares warning for other users Todd Engel claims Ozempic caused his total vision loss from NAION and has filed a lawsuit against Novo Nordisk over inadequate drug warnings.
October 14, 2026 Selma Blair's lawyer cites missed medication, head injury after in-flight arrest: What doctors say Selma Blair's attorney claims she missed doses of a powerful MS medication, triggering severe neurological symptoms before her in-flight arrest.
October 13, 2026 Popular erectile dysfunction pill may deliver additional boost to aging men Tadalafil boosted muscle precursor cell survival in a lab study, but researchers say the active Cialis ingredient also delayed mature muscle development.
October 11, 2026 New belly fat injection cuts dangerous fat surrounding organs by 12% in early human trial CBL-514 injection triggers apoptosis only in fat cells to reduce visceral fat by 12% in early trials, with implications for insulin resistance.
October 7, 2026 People on weight-loss drugs report fingernails falling off as researchers uncover surprising link Nail discoloration was reported by 46% of GLP-1 users versus 17% of non-users, while scalp inflammation accompanied hair loss in most medication users studied.
October 5, 2026 Alzheimer’s risk linked to compound found in popular joint health supplements University of Florida researchers found glucosamine users with mild cognitive impairment were 25% more likely to progress to dementia in a new study.
October 1, 2026 What to know about pentobarbital after death row inmate survives 2 lethal injection doses A look at pentobarbital reveals why the barbiturate used in Christa Gail Pike's failed lethal injection may not have reached fatal concentrations.
September 30, 2026 Rapid weight loss on popular drugs could ‘starve’ the brain, expert warns Dr. Tommy Wood warns GLP-1 drugs like Ozempic and Wegovy can shrink brain tissue when caloric restriction cuts off vital energy the brain needs.
September 28, 2026 Popular weight-loss drugs can become an ‘atomic bomb’ at high doses, doctor warns Dr. Will Cole warns that macro-dosing GLP-1s isn't the answer to metabolic health, advocating for micro-dosing peptides paired with lifestyle changes.
September 25, 2026 Popular weight-loss drugs may play surprising role in cancer outcomes GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.